companydata.dkcompanydata.dk

Cymab ApS: Financial statements 2025

CVR: 39859173

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Cymab ApS (CVR 39859173) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -5,463,240 and a net result of DKK -7,576,022 compared with DKK -4,627,624 the year before. Equity in the 2025 report amounted to DKK -20,227,476. The company had 3 employees in the financial year.

Gross Profit
DKK -5,463,240
Profit/Loss
DKK -7,576,022
Equity
DKK -20,227,476
Total Assets
DKK 5,778,529
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--5.5M-7.6M-20.2M3
2024--2M-4.6M-12.7M3
2023--1.2M-2.6M-8M2
20220-1.2M-1.5M-5.4M2
2021--567K-943K-3.9M1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Cymab ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Cymab ApS: The 2024 annual report is outJun 16, 2025

Cymab ApS has published its annual report for 2024. Gross profit came to DKK -1,951,697, and the net result was DKK -4,627,624.

Cymab ApS appoints new auditorFeb 25, 2025

As of February 25, 2025, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Cymab ApS.

Auditor steps down at Cymab ApSFeb 25, 2025

As of February 25, 2025, Slotsgade Revision ApS has stepped down as auditor of Cymab ApS.

About Cymab ApS

Cymab ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Ebumab ApS. The management consists of Johan Henrik Faber. The board consists of Hans Heugh Wandall (chair), Johan Henrik Faber, Mads Nikolaj Behrndt-Eriksen and Søren Erik Bjørn. The company is owned by Ebumab Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK -5,463,240 and a net result of DKK -7,576,022 compared with DKK -4,627,624 the year before. Equity in the 2025 report amounted to DKK -20,227,476.

Source: annual report 2025, Danish Business Authority

Other financial years